EVIDENCE LIBRARY
Mixed Carbamazepine–Alprazolam Case Could Not Assign Coma to One Agent From Symptoms Alone
A case report described fluctuating consciousness during mixed intoxication. Its clinical picture did not provide a benzodiazepine-only concentration–effect threshold.
A case report described fluctuating consciousness during mixed intoxication. Its clinical picture did not provide a benzodiazepine-only concentration–effect threshold.
The exposures and signs
The patient had epilepsy treated with carbamazepine and an alprazolam prescription for anxiety-related symptoms. The reported overdose involved both medicines.
Marked fluctuations, hypotonia, coma, and abnormal gaze were described. The article discussed carbamazepine toxicity features, but the actual patient’s mixed exposure remained part of the case.
Do not import a single-drug table
A concentration table drawn from other literature cannot establish how much of this patient’s presentation came from carbamazepine versus alprazolam or their combination. Clinical variability, timing, absorption, and other conditions matter.
The case does not establish an ingested benzodiazepine dose from the depth of coma. For a toxicology opinion, retain the available concentrations and their times, treatment, serial examination, and alternative causes. A characteristic symptom pattern can guide assessment without becoming exclusive proof of one drug’s contribution.
Source paper
Original analysis of the supplied journal article, identified as PMC9331306.